🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if the investigational drug GTx-0...
Status
Completed
Location
GTx Investigative Site
Start Date
2011-07
Trial ID
NCT01355484
The purpose of this study is to determine if the investigational drug GTx-0...
Status
Completed
Location
GTx Investigative Site
Start Date
2011-07
Trial ID
NCT01355497
To evaluate the impact of a selective androgen receptor modulator combined ...
Status
Completed
Location
Wellend Health
Start Date
2017-02-01
Trial ID
NCT03264651
Treatments Being Tested
The primary objective of this study is to assess the effect of enobosarm on...
Status
Recruiting
Location
DM Clinical Research - Phoenix
Start Date
2026-03-26
Trial ID
NCT07446998
Treatments Being Tested
The purpose of this study is to determine whether GTx-024 is safe and effec...
Status
Completed
Location
William Beaumont Hospital
Start Date
2016-01
Trial ID
NCT02658448
Treatments Being Tested
This open-label extension study, for subjects from the G201002 study, will ...
Status
Withdrawn
Location
Urology Center of Alabama
Start Date
2018-06-28
Trial ID
NCT03566290
Treatments Being Tested
To demonstrate the efficacy of enobosarmin the treatment of androgen recept...
Status
Terminated
Location
Ironwood Cancer and Research Centers
Start Date
2021-10-12
Trial ID
NCT04869943
Treatments Being Tested
This is a multiple site, proof of concept feasibility study to describe the...
Status
Withdrawn
Location
University of Washington, School of Medicine
Start Date
2016-04
Trial ID
NCT02746328
Treatments Being Tested
This phase II trial studies the side effects and how well pembrolizumab and...
Status
Completed
Location
City of Hope Corona
Start Date
2017-06-01
Trial ID
NCT02971761
Treatments Being Tested
STAGE 1: To determine the safety of enobosarm 9 milligram (mg) once daily (...
Status
Terminated
Location
Ironwood Cancer & Research Centers
Start Date
2022-04-11
Trial ID
NCT05065411